Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
Washington University School of Medicine
University of Nebraska
Var2 Pharmaceuticals
Washington University School of Medicine
Travera Inc
GONGCHU Biotechnology Co., Ltd
Turning Point Therapeutics, Inc.
Institut du Cancer de Montpellier - Val d'Aurelle
Stanford University
European Organisation for Research and Treatment of Cancer - EORTC